Vaccines segment

DVAX

Dynavax Technologies Corporation - Common Stock

-7.72% -7.72% 0

+ Immunology, Biology, Biopharma, Medicine, Vaccines Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.